-
Effectiveness and safety of mirikizumab as induction and maintenance therapy in patients with moderately to severely active ulcerative colitis?
-
-
Epub May 8, 2024
|
-
How effective is transabdominal ultrasonography in predicting the relapse of Crohn’s Disease?
-
-
Epub February 6, 2024
|
-
Comparative outcomes of acute colonic diverticulitis in immunocompromised versus immunocompetent patients: a systematic review and meta-analysis
-
-
Epub October 27, 2023
|
-
Does CVC placement increase the risk of venous thromboembolism in hospitalized IBD patients without pharmacological prophylactic antithrombotic therapy?
-
-
Epub August 3, 2023
|
-
Concomitant ankylosing spondylitis with inflammatory bowel disease: Clinical significance in terms of clinical outcomes
-
-
Epub May 9, 2023
|
-
Are the incidence rates of hospitalized infections, herpes zoster, and malignancies different depending on treatment drugs in patients with ulcerative colitis?
-
-
Epub February 3, 2023
|
-
Can educational training decrease excessive and inappropriate steroid use in patients with inflammatory bowel disease?
-
-
Epub November 3, 2022
|
-
Is bile acid metabolism related to dysbiosis in patients with Crohn’s disease?
-
-
Epub August 1, 2022
|
-
Is fecal microbiota transplantation effective in corticosteroid-dependent ulcerative colitis?
-
-
Epub April 29, 2022
|
-
Are thiopurines safe and effective for patients with NUDT15 heterozygosity?
-
-
Epub February 7, 2022
|
-
How often is immunoglobulin A nephropathy associated in patients with inflammatory bowel diseases?
-
-
Epub November 2, 2021
|
-
Could the geographic area influence the demographic profile of IBD patients in India?
-
-
Epub April 29, 2021
|
-
Could melatonin ameliorate the intestinal inflammation by modulating intestinal microbial composition?
-
-
Epub August 10, 2020
|
-
What are the risk factors for impaired ovarian reserve in young women of reproductive age with Crohn's disease?
-
-
Epub April 22, 2020
|
-
Who should continue the budesonide 2-mg foam treatment for up to week 6 in patients with mild-to-moderate distal ulcerative colitis?
-
-
Epub February 18, 2020
|
-
How common is family history of inflammatory bowel disease and how does it relate to the prognosis in patients with inflammatory bowel disease in Asia?
-
-
Epub October 13, 2019
|
-
Adherence to Asacol once daily versus divided regimen for maintenance therapy in ulcerative colitis: a prospective, multicenter, randomized study
-
-
Epub August 2, 2019
|
-
Influence of anti-tumor necrosis factor-alpha therapy on pregnant women with inflammatory bowel disease and their children’s immunity
-
-
Epub April 23, 2019
|
-
Efficacy of fecal microbiota therapy in steroid dependent ulcerative colitis: a real world intention-to-treat analysis
-
-
Epub February 7, 2019
|
-
Fecal immunochemical test and fecal calprotectin in ulcerative colitis
-
-
Epub November 1, 2018
|
-
Nonimmunity against hepatitis B virus infection in patients newly diagnosed with inflammatory bowel disease
-
-
Epub August 9, 2018
|
-
Comparison of efficacy of once daily multimatrix mesalazine 2.4 g/day and 4.8 g/day with other 5-aminosalicylic acid preparation in active ulcerative colitis: a randomized, double-blind study
-
-
Epub May 8, 2018
|
-
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment
-
-
Epub February 5, 2018
|
-
Efficacy and safety of ustekinumab in Japanese patients with moderately to severely active Crohn's disease
-
-
Epub November 2, 2017
|
-
Long-term safety and efficacy of adalimumab for intestinal Behçet's disease
-
-
Epub September 1, 2017
|
